|
|
DeciZen
|
||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 |
Q
V
PT
|
20,745 Small Cap |
8,262 (-0.43%) |
110.63 | 23.77 | 15.59 | 20.47 |
|
|
| 2 |
Q
V+
PT
|
10,662 Small Cap |
4,582 (-1.02%) |
41.34 | 23.6 | 0.00 | 0.00 |
|
|
| 3 |
Q
V+
PT
|
10,560 Small Cap |
6,294 (-1.06%) |
32.3 | 20.13 | 4.31 | 11.97 |
|
|
| 4 |
Q
V+
PT
|
1,61,290 Large Cap |
4,806.05 (0.85%) |
74.55 | 19.23 | 11.80 | 13.74 |
|
|
| 5 |
Q
V+
PT
|
30,215 Small Cap |
3,509.75 (-4.90%) |
82.52 | 18.11 | 32.80 | 16.82 |
|
|
| 6 |
Q
V
PT
|
40,535 Mid Cap |
2,390.75 (-0.08%) |
39.13 | 17.75 | 5.49 | 17.52 |
|
|
| 7 |
Q
V+
PT
|
12,453 Small Cap |
1,980.80 (-2.72%) |
67.37 | 16.69 | 19.49 | 18.67 |
|
|
| 8 |
Q
V+
PT
|
21,545 Small Cap |
1,366.95 (4.93%) |
114.5 | 15.92 | 32.49 | 25.95 |
|
|
| 9 |
Q
V+
PT
|
83,293 Mid Cap |
1,527 (-0.96%) |
93.72 | 15.79 | 7.19 | -2.25 |
|
|
| 10 |
Q
V+
PT
|
8,832 Small Cap |
543.65 (-2.03%) |
54.05 | 15.26 | 10.88 | 8.62 |
|
|
| 11 |
Q
V+
PT
|
12,712 Small Cap |
288.55 (-1.95%) |
347.16 | 14.78 | 0.00 | 0.00 |
|
|
| 12 |
Q
V+
PT
|
14,043 Small Cap |
1,334.25 (-2.24%) |
81.19 | 14.67 | 15.00 | 18.43 |
|
|
| 13 |
Q
V+
PT
|
4,209 Small Cap |
382.75 (-0.92%) |
90.17 | 14.63 | 12.12 | 15.55 |
|
|
| 14 |
Q
V
PT
|
43,364 Mid Cap |
773.50 (0.49%) |
64.67 | 13.76 | 13.62 | 19.07 |
|
|
| 15 |
Q
V+
PT
|
24,270 Small Cap |
18,890 (-0.14%) |
66.84 | 13.01 | 14.13 | 64.99 |
|
|
| 16 |
Q
V+
PT
|
1,27,930 Large Cap |
8,854.30 (-0.48%) |
85.71 | 12.84 | -3.49 | 29.94 |
|
|
| 17 |
Q
V+
PT
|
3,366 Small Cap |
545.25 (-0.79%) |
N/A | 11.8 | -8.75 | 0.00 |
|
|
| 18 |
Q
V
PT
|
54,930 Mid Cap |
26,850 (3.87%) |
35.39 | 11.51 | 9.38 | 18.78 |
|
|
| 19 |
Q
V
PT
|
27,596 Small Cap |
1,668.90 (1.38%) |
54.3 | 11.47 | 12.18 | 13.26 |
|
|
| 20 |
Q
V
PT
|
1,79,471 Large Cap |
6,800 (0.58%) |
69.89 | 10.71 | 11.65 | 10.50 |
|
|
| 21 |
Q
V+
PT
|
26,663 Small Cap |
1,231.25 (-1.97%) |
78.08 | 10.63 | 17.75 | 11.20 |
|
|
| 22 |
Q
V+
PT
|
1,12,230 Mid Cap |
1,145.45 (-0.67%) |
77.81 | 10.44 | 46.01 | 60.18 |
|
|
| 23 |
Q
V
PT
|
7,890 Small Cap |
3,418.90 (-0.21%) |
25.47 | 10.12 | -8.74 | -7.50 |
|
|
| 24 |
Q
V+
PT
|
37,944 Small Cap |
2,381 (0.75%) |
56.29 | 9.4 | 15.51 | 9.89 |
|
|
| 25 |
Q
V
PT
|
34,846 Small Cap |
1,823.35 (-0.75%) |
47.54 | 9.39 | 13.02 | 9.98 |
|
|
| 26 |
Q
V+
PT
|
41,550 Mid Cap |
3,350.15 (0.73%) |
39.35 | 9.18 | 13.54 | 10.92 |
|
|
| 27 |
Q
V
PT
|
35,732 Small Cap |
825.40 (-2.98%) |
137.06 | 9.1 | 11.87 | 17.04 |
|
|
| 28 |
Q
V
PT
|
36,287 Small Cap |
1,356.75 (0.53%) |
73.13 | 9.02 | 16.83 | 34.86 |
|
|
| 29 |
Q
V
PT
|
40,911 Mid Cap |
1,981.45 (-1.02%) |
50.78 | 9.02 | 11.88 | 45.85 |
|
|
| 30 |
Q
V+
PT
|
41,071 Mid Cap |
793.80 (0.14%) |
105.82 | 8.98 | -13.71 | 0.61 |
|
|
Pharma - Today's Top Gainers
| Company Name | CMP | Price Change(%) |
|---|---|---|
| 390 | 12.77% | |
| 260.75 | 9.03% | |
| 288.65 | 8.74% | |
| 275 | 5.61% | |
| 1,366.95 | 4.93% |
Pharma - Today's Top Losers
| Company Name | CMP | Price Change(%) |
|---|---|---|
| 880.05 | -10.16% | |
| 3,509.75 | -4.90% | |
| 312.60 | -4.56% | |
| 37.60 | -4.35% | |
| 556.05 | -3.61% |
| Rank | Company | Market Capitalization 2026 (INR crores) |
|---|---|---|
| 1 | Astrazeneca Pharma India Ltd. | 20,745 Crore |
| 2 | Sanofi Consumer Healthcare India Ltd. | 10,662 Crore |
| 3 | Procter & Gamble Health Ltd. | 10,560 Crore |
| 4 | Torrent Pharmaceuticals Ltd. | 1,61,290 Crore |
| 5 | Acutaas Chemicals Ltd. | 30,215 Crore |
| 6 | Glaxosmithkline Pharmaceuticals Ltd. | 40,535 Crore |
| 7 | CORONA Remedies Ltd. | 12,453 Crore |
| 8 | Rubicon Research Ltd. | 21,545 Crore |
| 9 | Laurus Labs Ltd. | 83,293 Crore |
| 10 | Thyrocare Technologies Ltd. | 8,832 Crore |
You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.
Based on ROE, the best stocks in the Nifty Pharma companies index are:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | P/E | P/BV | EV/EBITDA | ROE |
|---|---|---|---|---|---|---|---|
| Abbott India Ltd. (M) | Very Good | 26,850 | 54,930 | 35.39 | 11.51 | 24.16 | 35.71 |
| Torrent Pharmaceuticals Ltd. (L) | Very Good | 4,806 | 1,61,290 | 74.55 | 19.23 | 39.18 | 29.04 |
| Ajanta Pharma Ltd. (M) | Very Good | 3,350 | 41,550 | 39.35 | 9.18 | 26.59 | 25.35 |
| Lupin Ltd. (M) | Somewhat Good | 2,488 | 1,13,215 | 21.23 | 5.04 | 12.28 | 20.83 |
| Zydus Lifesciences Ltd. (M) | Very Good | 1,148 | 1,13,815 | 22.58 | 4.38 | 13.82 | 20.74 |
Based on the past year's gain, the best performing stocks are:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | Yearly gain (%) |
|---|---|---|---|---|
| Laurus Labs Ltd. (M) | Very Good | 1,527 | 83,293 | 103 |
| JB Chemicals & Pharmaceuticals Ltd. (S) | Very Good | 2,381 | 37,944 | 44.17 |
| Torrent Pharmaceuticals Ltd. (L) | Very Good | 4,806 | 1,61,290 | 42.84 |
| Aurobindo Pharma Ltd. (M) | Very Good | 1,598 | 93,217 | 40.20 |
| Gland Pharma Ltd. (S) | Very Good | 2,445 | 40,588 | 31.30 |
| View More |
Stocks with the highest revenue growth in the past 5 years is:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | P/E | P/BV | EV/EBITDA | 5Y Sales Growth (%) |
|---|---|---|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals Ltd. (S) | Very Good | 2,381 | 37,944 | 56.29 | 9.40 | 34.09 | 15.51 |
| Mankind Pharma Ltd. (M) | Very Good | 2,524 | 1,04,535 | 51.30 | 6.38 | 32.20 | 14.65 |
| Ajanta Pharma Ltd. (M) | Very Good | 3,350 | 41,550 | 39.35 | 9.18 | 26.59 | 13.54 |
| Dr. Reddys Laboratories Ltd. (M) | Very Good | 1,365 | 1,14,730 | 27.34 | 3.04 | 15.25 | 12.09 |
| Torrent Pharmaceuticals Ltd. (L) | Very Good | 4,806 | 1,61,290 | 74.55 | 19.23 | 39.18 | 11.80 |
Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.
Stocks with the highest profit growth in the past 5 years is:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | P/E | P/BV | EV/EBITDA | 5Y Profit Growth (%) |
|---|---|---|---|---|---|---|---|
| Zydus Lifesciences Ltd. (M) | Very Good | 1,148 | 1,13,815 | 22.58 | 4.38 | 13.82 | 30.57 |
| Sun Pharmaceutical Industries Ltd. (L) | Very Good | 1,905 | 4,56,989 | 39.81 | 5.47 | 22.81 | 23.50 |
| Abbott India Ltd. (M) | Very Good | 26,850 | 54,930 | 35.39 | 11.51 | 24.16 | 18.78 |
| Dr. Reddys Laboratories Ltd. (M) | Very Good | 1,365 | 1,14,730 | 27.34 | 3.04 | 15.25 | 15.75 |
| Glenmark Pharmaceuticals Ltd. (M) | Very Good | 2,264 | 62,362 | 45.79 | 5.93 | 12.16 | 14.41 |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: